Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 17,051–17,075 of 27,380 studies, newest first · page 683 of 1096.

April 2015 25

  1. 2015-04-08

    Case-Based fMRI Analysis after Cognitive Rehabilitation in MS: A Novel Approach

    ✓ Peer-reviewed Prevention trials Frontiers in neurology

    Key finding: The occurrence of different and opposed response patterns after the same training indicates a risk in applying classical group statistics. +3 more findings

  2. 2015-04-07

    Is There a Need for Early Palliative Care in Patients With Life-Limiting Illnesses? Interview Study With Patients About Experienced Care Needs From Diagnosis Onward

    ✓ Peer-reviewed End-of-life care The American journal of hospice & palliative care

    Key finding: The early integration of specialist palliative care has been shown to benefit the quality of life of patients with advanced cancer. +3 more findings

  3. 2015-04-07

    Neuroplastic effects of combined computerized physical and cognitive training in elderly individuals at risk for dementia: an eLORETA controlled study on resting states

    ✓ Peer-reviewed Prevention trials Neural plasticity

    Key finding: A significant training effect was identified only after the combined training scheme: a decrease in the post- compared to pre-training activity of precuneus/posterior cingulate cortex in delta, theta, and beta bands. +1 more finding

  4. 2015-04-06

    Direct medical costs and source of cost differences across the spectrum of cognitive decline: a population-based study

    ✓ Peer-reviewed Digital health tools Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Cost estimates did not differ significantly between CN and MCI. +2 more findings

  5. 2015-04-06

    In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imaging

    ✓ Peer-reviewed Disease mechanisms Proceedings of the National Academy of Sciences of the United States of America

    Key finding: In this work, we used [F-18]FDDNP PET to detect brain patterns of neuropathology distribution in retired professional American football players with suspected CTE (n = 14) and compared results with those of cognitively intact controls (n = 28) and patients with Alzheimer's dementia (AD) (n = 24), a disease that has been cognitively associated with CTE. [F-18]FDDNP PET imaging results in the retired players suggested the presence of neuropathological patterns consistent with models of concussion wherein brainstem white matter tracts undergo early axonal damage and cumulative axonal injuries along subcortical, limbic, and cortical brain circuitries supporting mood, emotions, and behavior.

  6. 2015-04-06

    Oxidative stress involving changes in Nrf2 and ER stress in early stages of Alzheimer's disease

    ✓ Peer-reviewed Mild cognitive impairment Biochimica et biophysica acta

    Key finding: Oxidative stress and endoplasmic reticulum (ER) stress have been associated with Alzheimer's disease (AD) progression. +2 more findings

  7. 2015-04-04

    The aqueous phase of Alzheimer's disease brain contains assemblies built from ∼4 and ∼7 kDa Aβ species

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Further analysis of brain-derived ∼7 kDa Aβ species, the mechanism by which they assemble and the structures they form should reveal therapeutic and diagnostic opportunities.

  8. 2015-04-03

    Synaptic dysfunction and septin protein family members in neurodegenerative diseases

    ✓ Peer-reviewed Disease mechanisms Molecular neurodegeneration

    Key finding: Recent research has identified neurodegenerative disease-related changes in protein accumulation and aggregation, gene expression, and protein functions, which may contribute to imbalanced synaptic function. +4 more findings

  9. 2015-04-03

    Tau immunotherapy for Alzheimer's disease

    ✓ Peer-reviewed Drug development Trends in molecular medicine

    Key finding: Targeting pathological tau protein in Alzheimer's disease (AD) and related tauopathies has shown great potential in animal models. +3 more findings

  10. 2015-04-03

    Can Studies of Neuroinflammation in a TSPO Genetic Subgroup (HAB or MAB) Be Applied to the Entire AD Cohort?

    ✓ Peer-reviewed Biomarkers Journal of nuclear medicine : official publication, Society of Nuclear Medicine

    Key finding: This study suggests that information obtained from evaluating a subgroup of AD or MCI subject using second-generation TSPO tracers can be translated to the entire AD and MCI population. +4 more findings

  11. 2015-04-02

    Do cognitive interventions improve general cognition in dementia? A meta-analysis and meta-regression

    ✓ Peer-reviewed Cognitive tests and assessment BMJ open

    Key finding: Online literature databases and trial registers, previous systematic reviews and leading journals were searched for relevant randomised controlled trials. +3 more findings

  12. 2015-04-02

    Exercise and the heart: the good, the bad, and the ugly

    ✓ Peer-reviewed Prevention and risk European heart journal

    Key finding: In parallel with the extraordinary athletic milieu of physical performances previously considered unachievable, there is emerging data indicating that long-standing vigorous exercise may be associated with adverse electrical and structural remodelling in otherwise normal hearts.

  13. 2015-04 month only

    Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery: Design and Methods

    ✓ Peer-reviewed Clinical trials Journal of Neurotrauma

    Key finding: An evaluation of the neuroprotection intervention studies conducted over the last 30 years has indicated that a limited understanding of the underlying biological concepts and methodological design flaws are the major reasons for the failure of pharmacological agents to demonstrate efficacy. +1 more finding

  14. 2015-04-01

    Identifying patients with Alzheimer's disease using resting-state fMRI and graph theory

    ✓ Peer-reviewed Digital health tools Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology

    Key finding: Classification based on the resting-state fMRI can be used as a non-invasive and automatic tool to diagnosis of Alzheimer's disease. +3 more findings

  15. 2015-04-01

    Amyloid biomarkers in Alzheimer's disease

    ✓ Peer-reviewed Tau biomarkers Trends in pharmacological sciences

    Key finding: Biomarkers to monitor Aβ metabolism and aggregation directly in patients are important for further detailed study of the involvement of Aβ in disease pathogenesis and to monitor the biochemical effect of drugs targeting Aβ in clinical trials. +4 more findings

  16. 2015-04-01

    Care in the last year of life for community patients with heart failure

    ✓ Peer-reviewed End-of-life care Circulation. Heart failure

    Key finding: Although patient factors remain associated with differential healthcare utilization at the end of life, utilization declined over time and use of palliative care services increased. +2 more findings

  17. 2015-04-01

    End-of-life issues in advanced dementia: Part 1: goals of care, decision-making process, and family education

    ✓ Peer-reviewed End-of-life care Canadian family physician Medecin de famille canadien

    Key finding: Physicians should consider advanced dementia as a terminal disease for which there is a continuum of care that goes from palliative care with life-extending measures to symptomatic interventions only. +4 more findings

  18. 2015-04-01

    Recognizing acute delirium as part of your routine [RADAR]: a validation study

    ✓ Peer-reviewed End-of-life care BMC nursing

    Key finding: The RADAR tool proved to be efficient, reliable, sensitive and very well accepted by nursing staff. +2 more findings

  19. 2015-04-01

    TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets

    ✓ Peer-reviewed Brain tissue and pathology Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

    Key finding: However, recent studies show that almost all cases of ALS, as well as tau-negative frontotemporal dementia (FTD), share a common neuropathology characterized by the deposition of TAR-DNA binding protein (TDP)-43-positive protein inclusions, offering an attractive target for the design and testing of novel therapeutics. +3 more findings

  20. 2015-04-01

    Nuclear receptors license phagocytosis by trem2+ myeloid cells in mouse models of Alzheimer's disease

    ✓ Peer-reviewed TREM2 and immune genetics The Journal of neuroscience : the official journal of the Society for Neuroscience

    Key finding: The brain's immune cells migrate to and invest their processes within Aβ plaques but are unable to efficiently phagocytose and clear plaques from the brain. +3 more findings

  21. 2015-04-01

    Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs

    ✓ Peer-reviewed Mild cognitive impairment JAMA internal medicine

    Key finding: Low daytime SBP was independently associated with a greater progression of cognitive decline in older patients with dementia and MCI among those treated with AHDs. +4 more findings

  22. 2015-04-01

    Prediction of brain age suggests accelerated atrophy after traumatic brain injury

    ✓ Peer-reviewed Digital health tools Annals of neurology

    Key finding: TBI patients' brains were estimated to be older than their chronological age. +2 more findings

  23. 2015-04-01

    Itch prevalence and characteristics in a Hispanic geriatric population: a comprehensive study using a standardized itch questionnaire

    ✓ Peer-reviewed Disparities Acta dermato-venereologica

    Key finding: Chronic itch is a common problem in the studied Hispanic geriatric population, and its presence significantly correlates with xerosis, diabetes, and venous insufficiency.

  24. 2015-04-01

    Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals

    ✓ Peer-reviewed Prevention and risk The journal of nutrition, health & aging

    Key finding: None of the participants were diabetics, smokers, or met criteria for obesity. +3 more findings

  25. 2015-04-01

    Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer's Disease Cooperative Study Cognitive Function Instrument

    ✓ Peer-reviewed Genetics JAMA neurology

    Key finding: At 48 months, group differences between clinical progressors and non-progressors were significant for self (2.13, SE=0.45, P Conclusions and relevance Demonstrating long-term clinical benefit will be critical for the success of recently launched secondary prevention trials.

Browse the library by subject, with the full score breakdown →